# MilliporeSigma launches synthetic cholesterol product nine months early

MilliporeSigma launched a new high-purity synthetic cholesterol product for mRNA therapeutics, nine months ahead of schedule, increasing capacity by 50 times.

- Type: Product launch
- Announced: 2021-05-26
- Where: Darmstadt, Germany, Germany
- Status: announced
- Capacity: 50 times increase in capacity
- Products: synthetic cholesterol for mRNA vaccines
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [MilliporeSigma](https://endata.com/companies/7341.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/milliporesigma-accelerates-scale-up-of-lipids-to-meet-covid-19-demand-301298948.html), 2021-05-26: "With the introduction of our new SAFC® synthetic cholesterol product, we have increased our capacity by 50 times, helping biomanufacturers bring lifesaving therapies to patients faster."
- [newswire.ca](https://www.newswire.ca/news-releases/milliporesigma-accelerates-scale-up-of-lipids-to-meet-covid-19-demand-847004158.html), 2021-05-26: "With the introduction of our new SAFC® synthetic cholesterol product, we have increased our capacity by 50 times, helping biomanufacturers bring lifesaving therapies to patients faster."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.